InnoSyn

Headquartered in the Netherlands, and founded as a spin-off from DSM Group in 2017, InnoSyn has built a strong position as a specialist provider of outsourced chemical process research and development services across different sectors with a specific focus on pharmaceuticals and flavours & fragrances. Leveraging innovative and cost-efficient technologies such as biocatalysis, flow chemistry and chemocatalysis, the Company assists customers in developing scalable routes for the production of new chemical compounds or addressing cost challenges associated with existing products. InnoSyn also offers manufacturing capacity (non-GMP) for specific chemical products or enzymes on pilot plant scale.

Team

Buyout

Status

Current

Geography

Europe

Ownership

Majority

Segment

Pharma Services

Entry Date

2023

Key Figures

Current

Status

2017

Creation Date

60

Number of Employees

2023

Investment Date

Mérieux Participations 4

Fund Name

Key Contacts

Related companies